69 related articles for article (PubMed ID: 7122527)
21. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
[TBL] [Abstract][Full Text] [Related]
22. The effect of benzonal and benzamyl on the neurogenic (neurotic) experimental hypertension in dogs.
Melnikov EA
Cor Vasa; 1969; 11(2):122-7. PubMed ID: 5354350
[No Abstract] [Full Text] [Related]
23. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
[TBL] [Abstract][Full Text] [Related]
24. Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide.
Wong DT; Reid LR
Commun Psychopharmacol; 1980; 4(4):269-75. PubMed ID: 7273702
[No Abstract] [Full Text] [Related]
25. A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory.
Gibbs SE; D'Esposito M
Neuroscience; 2006 Apr; 139(1):359-71. PubMed ID: 16458442
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex.
Nitsche MA; Lampe C; Antal A; Liebetanz D; Lang N; Tergau F; Paulus W
Eur J Neurosci; 2006 Mar; 23(6):1651-7. PubMed ID: 16553629
[TBL] [Abstract][Full Text] [Related]
27. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
Wong DT; Threlkeld PG; Bymaster FP
Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
[TBL] [Abstract][Full Text] [Related]
28. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior.
Clemens JA; Okimura T; Smalstig EB
Arzneimittelforschung; 1993 Mar; 43(3):281-6. PubMed ID: 8489554
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic effects in man of a potent, long-acting dopamine receptor agonist.
Lemberger L; Crabtree RE
Science; 1979 Sep; 205(4411):1151-3. PubMed ID: 382359
[TBL] [Abstract][Full Text] [Related]
30. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
Hasan F; Leonard BE
Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
[No Abstract] [Full Text] [Related]
31. [Dopaminergic stimulation in cardiology: its current status and future strategies].
Cherchi A; Mercuro G
Cardiologia; 1987 Dec; 32(12):1631-9. PubMed ID: 3329022
[No Abstract] [Full Text] [Related]
32. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
Epstein M; Hollenberg NK
Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
[No Abstract] [Full Text] [Related]
33. Synthesis and structure-activity relationships of new (5R,8R,10R)-ergoline derivatives with antihypertensive or dopaminergic activity.
Ohno S; Adachi Y; Koumori M; Mizukoshi K; Nagasaka M; Ichihara K; Kato E
Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1463-73. PubMed ID: 7923470
[TBL] [Abstract][Full Text] [Related]
34. Agonism at 5-HT2B receptors is not a class effect of the ergolines.
Jähnichen S; Horowski R; Pertz HH
Eur J Pharmacol; 2005 Apr; 513(3):225-8. PubMed ID: 15862804
[TBL] [Abstract][Full Text] [Related]
35. Effects of sarafotoxin S6c on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
Matsuo G; Matsumura Y; Tadano K; Morimoto S
J Pharmacol Exp Ther; 1997 Feb; 280(2):905-10. PubMed ID: 9023305
[TBL] [Abstract][Full Text] [Related]
36. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
Olsen NV
Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
[TBL] [Abstract][Full Text] [Related]
37. [Antagonism of sulpiride to the action of ibopamine at the level of peripheral circulation].
Musacci GF; Longhini C; Ansani L; Artioli M; Dell'Acqua G; Fratti D
Cardiologia; 1982 Dec; 27(12):1163-9. PubMed ID: 6927474
[No Abstract] [Full Text] [Related]
38. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
[TBL] [Abstract][Full Text] [Related]
39. Dopamine modulates synaptic transmission in the nucleus of the solitary tract.
Kline DD; Takacs KN; Ficker E; Kunze DL
J Neurophysiol; 2002 Nov; 88(5):2736-44. PubMed ID: 12424308
[TBL] [Abstract][Full Text] [Related]
40. Dopamine: pharmacologic and therapeutic aspects.
Velasco M; Luchsinger A
Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
